Yongzhen Mo
Overview
Explore the profile of Yongzhen Mo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
2662
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang D, Zuo S, Ge J, Qu H, Wu J, Yi N, et al.
Sci China Life Sci
. 2025 Jan;
68(3):689-705.
PMID: 39754006
Circular RNAs (circRNAs) play pivotal roles in the development and progression of various diseases, including malignant tumors. However, the biological functions and the underlying mechanisms of many circRNAs remain elusive....
2.
Shi Q, Wang X, Zhao D, Tang W, Mo Y
Coron Artery Dis
. 2024 Dec;
PMID: 39692438
Objective: To assess the impact of perceived stress levels in patients undergoing percutaneous coronary intervention (PCI) on the occurrence of major adverse cardiovascular events (MACEs) within a 6-month follow-up period...
3.
Wang D, Tang L, Chen M, Gong Z, Fan C, Qu H, et al.
ACS Nano
. 2024 Oct;
18(45):31055-31075.
PMID: 39467079
Nasopharyngeal carcinoma (NPC) is a common malignant tumor of the head and neck, prevalent in regions such as Southern China and Southeast Asia. Radiotherapy serves as the primary clinical treatment...
4.
Yang M, Mo Y, Ren D, Hu Y, Tian Y, Zeng Z, et al.
Mol Cell Probes
. 2024 Aug;
77:101975.
PMID: 39111403
Recently, it has been discovered surprisingly that tRNA can be cleaved into specific small fragments under certain conditions. Most importantly, these tRNA-derived fragments (tRFs) participate in the regulation of gene...
5.
Li L, Tang Q, Ge J, Wang D, Mo Y, Zhang Y, et al.
Clin Transl Med
. 2024 Jul;
14(7):e1766.
PMID: 39021049
Background: N-methyladenosine (mA) modification is essential for modulating RNA processing as well as expression, particularly in the context of malignant tumour progression. However, the exploration of mA modification in nasopharyngeal...
6.
Huang M, Liu Y, Yan Q, Peng M, Ge J, Mo Y, et al.
Cell Oncol (Dordr)
. 2024 Jan;
47(3):733-757.
PMID: 38170381
Background: Natural killer (NK) cells have gained considerable attention and hold great potential for their application in tumor immunotherapy. This is mainly due to their MHC-unrestricted and pan-specific recognition capabilities,...
7.
Zhou R, Chen S, Wu Q, Liu L, Wang Y, Mo Y, et al.
Cancer Lett
. 2023 Sep;
573:216381.
PMID: 37660884
In recent years, there have been multiple breakthroughs in cancer immunotherapy, with immune checkpoint inhibitors becoming the most promising treatment strategy. However, available drugs are not always effective. As an...
8.
Wang Q, Zhi Y, Zi M, Mo Y, Wang Y, Liao Q, et al.
Adv Sci (Weinh)
. 2023 Aug;
10(30):e2302558.
PMID: 37632718
Single cell RNA sequencing (scRNA-seq) provides a great convenience for studying tumor occurrence and development for its ability to study gene expression at the individual cell level. However, patient-derived tumor...
9.
Wang X, Mo Y, Yuan Y, Zhou Y, Chen Y, Sheng J, et al.
BMC Palliat Care
. 2023 Aug;
22(1):113.
PMID: 37543565
Background: The role of palliative care for end-stage renal disease (ESRD) patients have been proven in some developed countries, but it is still unclear in the mainland of China. In...
10.
Wu P, Hou X, Peng M, Deng X, Yan Q, Fan C, et al.
Cell Death Differ
. 2023 May;
30(7):1679-1694.
PMID: 37173390
Circular RNAs (circRNAs) play an important regulatory role in the pathogenesis and progression of nasopharyngeal carcinoma (NPC), which have not been thoroughly elucidated. In this study, we revealed for the...